These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26007164)

  • 1. Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?
    Han S; Li X; Qiu B; Jiang T; Wu A
    J Neurooncol; 2015 Aug; 124(1):45-55. PubMed ID: 26007164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.
    Mistry AM; Hale AT; Chambless LB; Weaver KD; Thompson RC; Ihrie RA
    J Neurooncol; 2017 Jan; 131(1):125-133. PubMed ID: 27644688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.
    Steed TC; Treiber JM; Taha B; Engin HB; Carter H; Patel KS; Dale AM; Carter BS; Chen CC
    J Neurooncol; 2020 Jul; 148(3):455-462. PubMed ID: 32556864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum.
    Mistry AM; Dewan MC; White-Dzuro GA; Brinson PR; Weaver KD; Thompson RC; Ihrie RA; Chambless LB
    J Neurooncol; 2017 Apr; 132(2):341-349. PubMed ID: 28074322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of glioblastoma multiforme to the subventricular zone is associated with survival.
    Jafri NF; Clarke JL; Weinberg V; Barani IJ; Cha S
    Neuro Oncol; 2013 Jan; 15(1):91-6. PubMed ID: 23095230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of glioblastoma mass effect by lateral ventricle displacement.
    Steed TC; Treiber JM; Brandel MG; Patel KS; Dale AM; Carter BS; Chen CC
    Sci Rep; 2018 Feb; 8(1):2827. PubMed ID: 29434275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
    Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
    Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma.
    Mineo JF; Bordron A; Baroncini M; Maurage CA; Ramirez C; Siminski RM; Berthou C; Dam Hieu P
    J Neurooncol; 2007 Dec; 85(3):281-7. PubMed ID: 17571214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
    Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
    Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.
    Zhang S; Qi Q
    J Neurooncol; 2015 Feb; 121(3):425-31. PubMed ID: 25385572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glioblastomas: clinical study and search for prognostic factors].
    Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
    Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-IR: a new prognostic biomarker for human glioblastoma.
    Maris C; D'Haene N; Trépant AL; Le Mercier M; Sauvage S; Allard J; Rorive S; Demetter P; Decaestecker C; Salmon I
    Br J Cancer; 2015 Sep; 113(5):729-37. PubMed ID: 26291053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
    Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
    J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
    Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
    Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.